Who Just RaisedStaten Island, NY · Health Care · Form D filed Sep 18, 2026
GevRx Nutraceuticals, Inc. raised $300K
GevRx Nutraceuticals, Inc. is a biotechnology company based in Staten Island, New York. In a Form D filed with the SEC on September 18, 2026, it reported raising $300,000 from 1 investor as part of an offering of up to $3,000,000. The first sale in the offering took place on September 11, 2026.
- First Form D. This is the first new Form D notice the company has filed with the SEC: likely its first priced outside round.
- Still raising. $2.7M of the $3M offering was still unsold at filing.
$300K raised since 2020
1 Form D offering, as reported to the SEC. Amendments update a round; they aren't counted twice.
| Filed | Sold | Offering size | Investors |
|---|---|---|---|
| Sep 18, 2026 | $300K | $3M | 1 |
Lead score
39 out of 100
filed recently first raise ever still raising young company
Outreach kit How it works 1:21
A first message that shows you did your homework, written from this filing. Fill in the brackets and send.
Email · subject: Congrats on the new round
Hi [first name], Congrats on the new round. I saw the raise in your SEC filing. Teams at this stage usually start looking at [what you do] right after a round... [Your name]
LinkedIn note
Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?
Call opener
Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...
Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing
Track this company How it works 0:56
Saved to your dashboard pipeline, with a badge in Explore.
Loading your outreach kit…
The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.
Filing details
- Amount raised
- $300,000
- Offering size
- $3,000,000
- Investors so far
- 1
- First sale
- September 11, 2026
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Biotechnology
- Headquarters
- Staten Island, New York
- Incorporated
- Delaware, 2026
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $300,000 | $3,000,000 | 1 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Updated · Raises in the week of Sep 14, 2026 · Health Care funding in New York · September 2026 funding report
Similar raises
Hypercell Technologies Inc.
Ithaca, NY · filed Oct 142nd Form D since 2021Still raising
Frictionworx Inc.
Brooklyn, NY · filed Oct 13First Form DStill raising
Atmos Clinic, Inc.
New York, NY · filed Oct 8
Affordable healthcare for working people. You set a monthly allowance, your team picks the care they need, and Atmos handles the paperwork and the IRS.
First Form DStill raising
PreciseDx, Inc.
New York, NY · filed Oct 7
Current standards of care in oncology can be subjective, leading to a high percentage of tumors receiving intermediate grading. As a result, many patients are forced to anxiously await the results of…
3rd Form D since 2024
CAD Therapeutics, Inc.
New York, NY · filed Oct 2CAD Therapeutics is developing Clonicaine™, an investigational Phase III-candidate program for PTSD focused on the physiological dimension of the condition. Clonicaine™ is not FDA-approved and is not…
First Form DStill raising
Click Therapeutics, Inc.
New York, NY · filed Oct 1
We combine neuroscience with the power of software to create patient-centric digital treatments. Discover our prescription digital therapeutics and software-enhanced drug therapies.
10th Form D since 2014
Amani Therapeutics, Inc.
New York, NY · filed Oct 12nd Form D since 2025Still raising
Precision Neuroscience Corp
New York, NY · filed Sep 28
5th Form D since 2021